The human microbiome and public health: Social and ethical considerations

American Journal of Public Health

Volumn 106, Issue 3, 2016, Pages 414-420

  O'Doherty, Kieran C ^a   Virani, Alice ^b   Wilcox, Elizabeth S ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MICROBIOME; PUBLIC HEALTH; CULTURAL ANTHROPOLOGY; DIET; ENVIRONMENT; HEALTH STATUS; IMMUNE SYSTEM; MICROBIOLOGY; MICROFLORA; NEWBORN; OBESITY; OBSTETRIC DELIVERY; PROCEDURES; RESEARCH ETHICS; SOCIAL ENVIRONMENT;

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ANTI-BACTERIAL AGENTS; CULTURE; DELIVERY, OBSTETRIC; DIET; ENVIRONMENT; ETHICS, RESEARCH; HEALTH STATUS; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; MICROBIOTA; OBESITY; PROBIOTICS; PUBLIC HEALTH; SOCIAL ENVIRONMENT;

EID: 84959045841     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2015.302989     Document Type: Review

References (91)

1. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol. 2012;7:99-122.
2. Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, et al. The oral metagenomeinhealth and disease.ISME J.2012; 6(1):46-56.
3. Parfrey LW, Walters WA, Knight R. Microbial eu-karyotes in the human microbiome: ecology, evolution, and future directions. Front Microbiol. 2011;2:153.
4. Schloissnig S, Arumugam M, Sunagawa S, et al. Ge-nomic variation landscape of the human gut microbiome. Nature. 2013;493(7430):45-50.
5. Li J, Butcher J, Mack D, Stintzi A. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(1): 139-153.
6. Sommer F, Bäckhed F.The gut microbiota-masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227-238.
7. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152): 427-434.
8. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-810.
9. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587(Pt 17): 4153-4158.
10. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-484.
11. Blaser MJ. Harnessing the power of the human microbiome. Proc Natl Acad Sci U S A. 2010;107(14): 6125-6126.
12. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012; 67(5):456-463.
13. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2011;9(1):27-38.
14. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011; 108(suppl 1):4680-4687.
15. Chaban B, Links MG, Jayaprakash TP, et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Micro-biome. 2014;2:23.
16. Hill J, Jayaprakash T, Wagner E, Albert A, van Schalkwyk J, Money D. 650: Characterization of the vaginal microbiome following preterm premature rupture of membranes (PPROM). Am J Obstet Gynecol. 2015; 212(1 suppl):S320-S321.
17. Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics. 2012; 129(5):950-960.
18. Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002;35(suppl 1):S6-S16.
19. Gondalia SV, Palombo EA, Knowles SR, Austin DW. Gastrointestinal microbiology in autistic spectrum disorder: a review. Rev Med Microbiol. 2010;21(3): 44-50.
20. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407-415.
21. Allen-Vercoe E, Reid G, Viner N, et al. A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol. 2012;26(7):457-462.
22. Hill C, Guarner F, Reid G, et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
23. Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW, Versalovic J. Probiotics, enteric and di-arrheal diseases, and global health. Gastroenterology. 2011; 140(1):8-14.
24. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40(11):1025-1035.
25. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-1273.
26. Russell SL, Gold MJ, Hartmann M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13(5): 440-447.
27. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327-336.
28. Gibbons A. Evolution. How sweet it is: genes show how bacteria colonized human teeth. Science. 2013;339(6122):896-897.
29. Subramanian S, Huq S, Yatsunenko T, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510(7505):417-421.
30. Goldstein-Daruech N, Cope EK, Zhao KQ, et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS One. 2011;6(1):e15700.
31. Xu Z, Knight R. Dietary effects on human gut microbiome diversity. Br J Nutr. 2015;113(suppl):S1-S5.
32. Walter J, Ley R. The human gut microbiome:ecology and recent evolutionary changes. Annu Rev Microbiol. 2011;65:411-429.
33. Flint HJ, Duncan SH, Louis P. Gut microbiome and obesity. In: Kushner RF, Bessesen DH, eds. Treatment of the Obese Patient. New York, NY: Springer; 2014:73-82.
34. Dey N, Wagner VE, Blanton LV, et al. Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell. 2015; 163(1):95-107.
35. Kashyap PC. Eat your curry. Cell Host Microbe. 2015; 18(4):385-387.
36. Clarke SF, Murphy EF, O'Sullivan O, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014:63(12):1913-1920.
37. Barros AJ, Santos IS, Matijasevich A, et al. Patterns of deliveries in a Brazilian birth cohort: almost universal cesarean sections for the better-off. Rev Saude Publica. 2011;45(4):635-643.
38. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med. 2015;21(2): 109-117.
39. Bager P, Wohlfahrt J, Westergaard T. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin Exp Allergy. 2008;38(4):634-642.
40. Barros FC, Matijasevich A, Hallal PC, et al. Cesarean section and risk of obesity in childhood, adolescence, and early adulthood: evidence from 3 Brazilian birth cohorts. Am J Clin Nutr. 2012;95(2):465-470.
41. Gregory KE. Microbiome aspects of perinatal and neonatal health. J Perinat Neonatal Nurs. 2011;25(2): 158-162; quiz 163-164.
42. Huffnagle GB. The microbiota and allergies/asthma. PLoS Pathog. 2010;6(5):e1000549.
43. Guilbert TW, Denlinger LC. Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med. 2010;4(1):71-83.
44. Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307): 307ra152.
45. Cabana MD, McKean M, Wong AR, Chao C, Caughey AB. Examining the hygiene hypothesis: the trial of infant probiotic supplementation. Paediatr Perinat Epidemiol. 2007;21(suppl 3):23-28.
46. Doege K, Grajecki D, Zyriax BC, Detinkina E, zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood-a meta-analysis. Br J Nutr. 2012; 107(1):1-6.
47. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2012;12(1): 9-23.
48. Lif Holgerson P, Harnevik L, Hernell O, Tanner AC, Johansson I. Mode of birth delivery affects oral microbiota in infants. J Dent Res. 2011;90(10):1183-1188.
49. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ. 1998;317 (7159):637-642.
50. Hulscher ME, Grol RP, van derMeer, JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10(3):167-175.
51. Sheehy A, Davis D, Homer CS. Assisting women to make informed choices about screening for Group B streptococcus in pregnancy: a critical review of the evidence. Women Birth. 2013;26(2):152-157.
52. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature. 2011;476(7361):393-394.
53. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3): 646-652.
54. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167(8):821-827.
55. Blaser MJ. An endangered species in the stomach. Sci Am. 2005;292(2):38-45.
56. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62(1):34-42.
57. Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9(12):894-896.
58. Arias CA, Murray BE. A new antibiotic and the evolution of resistance. N Engl J Med. 2015;372(12): 1168-1170.
59. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972-978.
60. Norris P, Chamberlain K, Dew K, Gabe J, Hodgetts D, Madden H. Public beliefs about antibiotics, infection and resistance: a qualitative study. Antibiotics. 2013;2(4): 465-476.
61. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes-what's missing? J Antimicrob Chemother. 2010;65(11):2275-2277.
62. Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis. 2012;54(5):707-713.
63. Forslund K, Sunagawa S, Kultima JR, et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 2013;23(7):1163-1169.
64. O'Doherty KC, NeufeldJD, Brinkman FS, Gardner H, Guttman DS, Beiko RG. Opinion: conservation and stewardship of the human microbiome. ProcNatl Acad Sci USA. 2014;111(40):14312-14313.
65. Missaghi B, Barkema HW, Madsen KL, Ghosh S. Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens. 2014;3(3): 510-527.
66. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011;108(suppl 1): 4578-4585.
67. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26): 11971-11975.
68. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5(7):e177.
69. Gutierrez-Achury J, Coutinho de Almeida R, Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med. 2011;269(6): 591-603.
70. Schwarz S, Morelli G, Kusecek B, et al. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008;4(10):e1000180.
71. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011;9(4):279-290.
72. Meadow JF, Bateman AC, Herkert KM, O'Connor TK, Green JL. Significant changes in the skin microbiome mediated by the sport of roller derby. PeerJ. 2013;1:e53.
73. Kort R, Caspers M, van de Graaf A, van Egmond W, Keijser B, Roeselers G. Shaping the oral microbiota through intimate kissing. Microbiome. 2014;2:41
74. Mandar R, Punab M, Borovkova N, et al. Complementary seminovaginal microbiome in couples. Res Microbiol. 2015;166(5):440-447.
75. Laursen MF, Zachariassen G, Bahl MI, et al. Having older siblings is associated with gut microbiota development during early childhood. BMC Microbiol. 2015;15: 154.
76. Song SJ, Lauber C, Costello EK, et al. Cohabiting family members share microbiota with one another and with their dogs. Elife. 2013;2:e00458.
77. Mullin GE, Delzenne NM. The human gut microbiome and its role in obesity and the metabolic syndrome. In: Mullin GE, Cheskin LJ, Matarese LE, eds. Integrative Weight Management. New York: Springer; 2014:71-105.
78. Hummelen R, MacklaimJM, Bisanz JE, et al. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One. 2011;6(11):e26602.
79. Hummelen R, Changalucha J, Butamanya NL, et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes. 2011;2(2):80-85.
80. Childress JF, Faden RR, Gaare RD, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002; 30(2):170-178.
81. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PLoS One. 2014;9(11):e111030.
82. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database SystRev. 2011;(9):CD006895.
83. Foster JA, McVey Neufeld KM. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312.
84. Hrudey SE, Huck PM, Payment P, Gillham RW, Hrudey EJ. Walkerton: lessons learned in comparison with waterborne outbreaks in the developed world. J Environ Eng Sci. 2002;1(6):397-407.
85. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131(2):445-450; quiz 660.
86. Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins S. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004;20(11-12):1317-1322.
87. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-1412.
88. Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care. 2011;14(6):581-587.
89. Sherman PM, OssaJC, Wine E. Bacterial infections: new and emerging enteric pathogens. Curr Opin Gastroenterol. 2010;26(1):1-4.
90. Harrison KL, Farrell RM, Brinich MA, et al. 'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics. Health Expect. 2015;18(2):250-261.
91. O'Doherty KC, Hawkins AK, Burgess MM. Involving citizens in the ethics of biobank research: informing institutional policy through structured public deliberation. Soc Sci Med. 2012;75(9):1604-1611.